|
Torrent Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
106312.48 Cr.
|
P/BV
|
14.17
|
Book Value (Rs.)
|
221.73
|
|
52 Week High/Low (Rs.)
|
3591/2520
|
FV/ML
|
5/1
|
P/E(X)
|
64.18
|
|
Bookclosure
|
01/02/2025
|
EPS (Rs.)
|
48.94
|
Div Yield (%)
|
0.89
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 10562.31 | 9463.69 | 8418.80 | 7886.23 | 7780.01 |
| Other Operating Revenues | 165.53 | 156.46 | 89.24 | 118.34 | 159.30 |
| Total Operating Revenues | 10727.84 | 9620.15 | 8508.04 | 8004.57 | 7939.31 |
| | | | | | |
| Other Income | 57.91 | 45.14 | 196.56 | 56.91 | 121.30 |
| Total Revenue | 10785.75 | 9665.29 | 8704.60 | 8061.48 | 8060.61 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1657.59 | 1480.42 | 1537.50 | 1420.69 | 1377.35 |
| Purchase Of Stock-In Trade | 1183.63 | 1088.58 | 830.65 | 1004.97 | 922.70 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -155.01 | 166.19 | 73.86 | -279.24 | -133.13 |
| Employee Benefit Expenses | 1984.40 | 1677.69 | 1526.45 | 1439.62 | 1429.04 |
| Finance Costs | 353.56 | 333.44 | 255.06 | 352.94 | 450.71 |
| Depreciation And Amortisation Expenses | 808.27 | 706.59 | 662.16 | 657.79 | 654.38 |
| Other Expenses | 2689.58 | 2365.22 | 2108.31 | 1938.45 | 2172.99 |
| Total Expenses | 8522.02 | 7818.13 | 6993.99 | 6535.22 | 6874.04 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2263.73 | 1847.16 | 1710.61 | 1526.26 | 1186.57 |
| | | | | | |
| Exceptional Items | 88.38 | 0.00 | -484.70 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 2352.11 | 1847.16 | 1225.91 | 1526.26 | 1186.57 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 461.73 | 354.77 | 346.22 | 334.08 | 260.24 |
| Deferred Tax | 234.00 | 227.62 | 106.53 | -52.98 | -59.23 |
| Tax For Earlier Years | 0.00 | 19.54 | -4.02 | -6.72 | -39.16 |
| Total Tax Expenses | 695.73 | 601.93 | 448.73 | 274.38 | 161.85 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1656.38 | 1245.23 | 777.18 | 1251.88 | 1024.72 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1656.38 | 1245.23 | 777.18 | 1251.88 | 1024.72 |
| | | | | | |
| Profit/Loss For The Period | 1656.38 | 1245.23 | 777.18 | 1251.88 | 1024.72 |
| Consolidated Profit/Loss After MI And Associates | 1656.38 | 1245.23 | 777.18 | 1251.88 | 1024.72 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 48.94 | 36.79 | 45.93 | 73.98 | 60.55 |
| Diluted EPS (Rs.) | 48.94 | 36.79 | 45.93 | 73.98 | 60.55 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 1015.34 | 863.04 | 676.89 | 338.45 | 609.20 |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 125.22 |
